Kayode Solomon Adedapo

Kayode Solomon Adedapo

Auto-generated profile, based on publicly available information

Kayode Solomon Adedapo

Department of Chemical Pathology, University College Hospital, Ibadan, Nigeria

Research Focus & Metrics

Academic Career Length

26Years (2001-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
13 March 2010
Verified
Journal Article
Open access
OOOo Oladapo
Oo Oladapo
AFAo Falase
Ao Falase
LSL Salako
L Salako
OSO Sodiq
O Sodiq
KSK Shoyinka
K Shoyinka
KAK Adedapo
K Adedapo
It has been hypothesised that rural sub-Saharan Africa is at an early stage of epidemiological transition from communicable to non-communicable diseases (NCD). Limited information exists about the prevalence of cardiometabolic risk factors and the burden of cardiovascular disease (CVD) in the adult Nigerian population, especially in the rural setting. The aim of this study was to assess and describe the prevalence of several cardiometabolic risk factors in the sub-Saharan adult population of a rural Yoruba community, living in south-western Nigeria. The study was a descriptive, cross-sectional, random-sample survey. Participants were visited at home by trained nurses and community health extension workers (CHEW) who administered a questionnaire, took the relevant history, carried out clinical examinations and measurements and took samples for laboratory tests. They were supervised by primary healthcare physicians serving the community. The variables recorded comprised clinical history, CVD risk factors including blood pressure (BP), body mass index (BMI), waist circumference, blood sugar and serum lipid levels, cigarette use, and dietary habits. The participants included 2 000 healthy adults aged 18 to 64 years who had been living in the area for more than three years. The average age was 42.1 ± 21.6, with 43.7% (873) being males and 56.3% (1127) females; 20.8% were hypertensive with BP ≥ 140/90 mmHg, 42.3% of the men and 36.8% of the women had BP ≥ 130/85 mmHg; 2.5% had diabetes, 1.9% had hypertriglycerideaemia, 43.1% had low HDL-C, 3.9% had general obesity, 14.7% had abdominal obesity, 3.2% were physically inactive, and 1.7% smoked cigarettes. Overall, 12.9% of the subjects were found to have at least one CVD risk factor. Using the Adult Treatment Panel (ATP) III criteria, 2.1% of men and 2.7% of women in the study population had at least three of the criteria, the commonest being HDL-C < 40 mg/dl in men or < 50 mg/dl in women, followed by BP ≥ 130/85 mmHg, then waist circumference > 88 cm in women or > 102 cm in men, followed by blood glucose ≥ 110 mg/dl. The results obtained from this study strongly suggest a high prevalence of cardiometabolic risk factors in this rural population and that the epidemiological transition is not restricted to the urban population. This serves as a wake-up call for action in the planning of health services for the management of CVD and other chronic NCDs.

1 April 2008 in Annals of Hepatology
Verified
Journal Article
Open access
JOJesse A. Otegbayo
Jesse A. Otegbayo
BTBabafemi O Taiwo
Babafemi O Taiwo
TATitilola S Akingbola
Titilola S Akingbola
GOGeorgina N. Odaibo
Georgina N. Odaibo
KAKayode S. Adedapo
Kayode S. Adedapo
PKPhyllis Kanki
Phyllis Kanki
The clinical and public health implications of the convergence of the human immunodeficiency virus (HIV) epidemic and chronic viral hepatitis in sub-Saharan Africa are poorly understood. This study was designed to determine the seroprevalence of hepatitis B virus (HBV) and hepatitis C virus (HCV), and the impact of co-infection on baseline serum alanine transaminase (ALT), CD4+ T lymphocyte (CD4) count, and plasma HIV-RNA (viral load) in a cohort of HIV-infected Nigerians. A retrospective study was conducted, on eligible treatment-naive patients who presented between August 2004 and February 2007 to the University College Hospital (UCH), Ibadan, Nigeria. Demographic data and pre-treatment laboratory results (hepatitis B surface antigen (HBsAg), HCV antibodies (anti-HCV), ALT, CD4 count and viral load) were retrieved from the medical records. Fisher's exact, two sample t-tests, and the Wilcoxon rank sum tests were used to compare groups. A logistic regression model was fitted to explore characteristics associated with co-infection status. A total of 1779 HIV-infected patients (male: female ratio, 1:2) met inclusion criteria. HBsAg was present in 11.9%, anti-HCV in 4.8% and both markers in 1%. HBsAg was more common among males than females (15.4% vs 10.1%, respectively p = 0.001) while anti-HCV was detected in a similar proportion of males and females (5.3% versus 4.6%, respectively p = 0.559). HIV-infected patients with anti-HCV alone had a lower mean baseline CD4 count compared to those without anti-HCV or HBsAg (197 cells/mm3 vs 247 cells/mm3, respectively p = 0.008). Serum ALT was higher among patients with HBsAg compared to those without HBsAg or anti-HCV (43 International Units (IU) vs. 39 IU, respectively p = 0.015). Male gender was associated with HBV co-infection on logistic regression (OR1.786; 95% CI, 1.306-2.443; p < 0.005). More HIV-infected females than males presented for care in this cohort. We identified a relatively high prevalence of HBV and HCV co-infection in general, and a higher rate of HBV co-infection among males than females. Pre-treatment CD4 count was significantly lower among those with HCV co-infection, while ALT was slightly higher among those with HBV co-infection. Triple infection with HIV, HBV and HCV was present in a small but significant proportion of patients. These findings underscore the importance of testing for HBV and HCV in all HIV-infected persons in our setting.

1 January 2013 in Indian Journal of Nuclear Medicine
Verified
Journal Article
Open access
PDF file
JEJohn Enyi Ejeh
John Enyi Ejeh
KAKayode Solomon Adedapo
Kayode Solomon Adedapo
YOYetunde Ajoke Onimode
Yetunde Ajoke Onimode
AAAdewale Oluwaseun Adepoju
Adewale Oluwaseun Adepoju
The role of nuclear medicine in disease management in a developing nation is as impactful as it is in other regions of the world. However, in the developing world, the practice of nuclear medicine is faced with a myriad of challenges, which can be easily avoided. In this review, we examine the many avoidable challenges to the practice of nuclear medicine in a developing nation. The review is largely based on personal experiences of the authors who are the pioneers and current practitioners of nuclear medicine in a typical developing nation. If the challenges examined in this review are avoided, the practice of nuclear medicine in such a nation will be more effective and practitioners will be more efficient in service delivery. Hence, the huge benefits of nuclear medicine will be made available to patients in such a developing nation.

23 May 2011 in Journal of Clinical Pathology
Verified
Journal Article
Closed access
PDF file
MKModupe Akinrele Kuti
Modupe Akinrele Kuti
FAFayeofori Mpakabaori Abbiyesuku
Fayeofori Mpakabaori Abbiyesuku
KAKehinde Akinlade
Kehinde Akinlade
OAOlubayo Michael Akinosun
Olubayo Michael Akinosun
KAKayode Solomon Adedapo
Kayode Solomon Adedapo
OAOlubukola Adeponle Adesina
Olubukola Adeponle Adesina
Aims This study aimed to determine the prevalence and relationships with known risk factors of gestational diabetes mellitus (GDM) at University College Hospital, Ibadan, Nigeria. Methods Records of all women referred for oral glucose tolerance testing at the metabolic research unit of the Hospital over a 2 year period were reviewed. Diagnosis of GDM was made in accordance with WHO criteria. GDM diagnosis was classified as early and late based on a gestational age 24 weeks respectively. Body mass index (BMI) measurements were performed for women who presented in the first trimester. Various statistical tools including student t test and Pearson's coefficient of correlation were used. Results A total of 765 records were reviewed. The crude prevalence rate was 13.9%. The prevalence rate among women in the first trimester was highest at 17.4% although most of the diagnoses were made in the third trimester (55.7%). A positive family history and a family history of GDM were associated significantly with a higher fasting and 2 h post-load glucose values, irrespective of current GDM diagnosis. The most consistent associations with a diagnosis of GDM were a positive family history and a history of GDM. Age above 30 years at oral glucose testing also showed significant association. There was no BMI threshold associated with a significant risk of GDM for those women presenting in the first trimester. Conclusions GDM is a common metabolic condition in Nigeria. Onset before the 24th week of pregnancy is not uncommon.

12 August 2012 in CardioVascular Journal of Africa
Verified
Journal Article
Open access
OOO.O Oladapo
O.O Oladapo
LSL Salako
L Salako
LSL Sadiq
L Sadiq
KSK Shoyinka
K Shoyinka
KAK Adedapo
K Adedapo
AFA.O Falase
A.O Falase
Cardiovascular Journal of Africa: Vol 23 No 7 (August 2012)

1 October 2005 in Annals of Hepatology
Verified
Journal Article
Open access
TKTaiwo Kotila
Taiwo Kotila
KAKayode Adedapo
Kayode Adedapo
AAAduragbenro Adedapo
Aduragbenro Adedapo
OOOlayiwola Oluwasola
Olayiwola Oluwasola
EFEyitayo Fakunle
Eyitayo Fakunle
BBBiobele Brown
Biobele Brown
The liver is one of the organs involved in the multiorgan failure that occurs in sickle cell disease, the pathophysiology of liver disease in this condition is complex because of the interrelated multifactorial causes. Liver dysfunction was assessed in both paediatric and adult sickle cell disease patients in the steady state. The transaminases and alkaline phosphatase were analysed by automation while coagulation studies were done manually. The mean (range) of Alanine transaminase (ALT), Aspartate transaminase (AST) and alkaline phosphatase (ALP) were 23.0 (2-77) IU, 48.5 (15-120) IU, 227.5 (37-1200) IU respectively. ALT and AST levels were less than 100 IU in over 95% of the patients. The gender or age of the patients did not significantly affect the level of these three enzymes. There was close association between the liver size and elevation of the liver enzymes except for alkaline phosphatase (ALT=.017, AST=.009, ALP=.056). Twenty-five percent of the patients had normal enzymes while 13% had derangement of the three enzymes, 19%, 50% and 74% had abnormal ALT, AST and ALP respectively. Only 22% and 5% had deranged PT and APTT respectively. In conclusion minimal elevation of the tramsaminases which is not gender or age dependent were observed in steady state sickle cell disease, higher levels of alkaline phosphatase may be due to associated vasoocclussive crises involving the bones rather than a pathology of the liver.